Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum

2021 ◽  
Author(s):  
Jumpei Saito ◽  
Mariko Ishii ◽  
Asako Mito ◽  
Naho Yakuwa ◽  
Hiroyo Kawasaki ◽  
...  
Author(s):  
Jumpei Saito ◽  
Asako Mito ◽  
Naho Yakuwa ◽  
Kayoko Kaneko ◽  
Hiroyo Kawasaki ◽  
...  

Rheumatology ◽  
2019 ◽  
Vol 58 (8) ◽  
pp. 1505-1507 ◽  
Author(s):  
Jumpei Saito ◽  
Naho Yakuwa ◽  
Kayoko Kaneko ◽  
Chinatsu Takai ◽  
Mikako Goto ◽  
...  

2018 ◽  
Vol 13 (2) ◽  
pp. 267-269 ◽  
Author(s):  
Entcho Klenske ◽  
Lourdes Osaba ◽  
Daniel Nagore ◽  
Timo Rath ◽  
Markus F Neurath ◽  
...  

2021 ◽  
Author(s):  
Jumpei Saito ◽  
Mariko Ishii ◽  
Yoriko Miura ◽  
Naho Yakuwa ◽  
Hiroyo Kawasaki ◽  
...  

DICP ◽  
1989 ◽  
Vol 23 (1) ◽  
pp. 56-57 ◽  
Author(s):  
Allan J. Ellsworth ◽  
John R. Horn ◽  
Vidmantas A. Raisys ◽  
Lea Ann Miyagawa ◽  
Judy L. Bell

Maternal serum and breast milk were obtained to determine the concentration of disopyramide (DP) and its metabolite N-monodesalkyl disopyramide (NMD) from a woman requiring antidysrhythmic drug therapy. Infant serum and urine were also obtained for drug concentrations. DP 450 mg tid resulted in peak maternal serum concentrations of 4.0 μg/mL and 2.2 μg/mL for DP and NMD, respectively. Breast milk concentrations averaged 1.06 and 6.24 times the serum levels for DP and NMD, respectively. No DP was measurable in the infant's serum except for cord blood, which contained 0.7 μg/mL DP, 26 percent of simultaneous maternal concentration, and 0.9 μg/mL NMD, which represented 43 percent of the maternal concentration. Infant urine collected over an eight-hour period contained 3.3 μg/mL of DP and 3.7 μg/mL of NMD.


2020 ◽  
Vol 15 (12) ◽  
pp. 809-812
Author(s):  
Jumpei Saito ◽  
Naho Yakuwa ◽  
Aiko Sasaki ◽  
Hiroyo Kawasaki ◽  
Tomo Suzuki ◽  
...  

2020 ◽  
Vol 15 (9) ◽  
pp. 598-601
Author(s):  
Jumpei Saito ◽  
Naho Yakuwa ◽  
Noriko Sandaiji ◽  
Hiroyo Kawasaki ◽  
Kayoko Kaneko ◽  
...  

2006 ◽  
Vol 52 (11) ◽  
pp. 2095-2102 ◽  
Author(s):  
Maria Weyermann ◽  
Christopher Beermann ◽  
Hermann Brenner ◽  
Dietrich Rothenbacher

Abstract Background: The presence of the adipokines adiponectin and leptin in cord blood and placental and fetal tissues suggests a possible role in fetal development. Methods: We measured concentrations of adiponectin and leptin in maternal serum, cord blood, and breast milk and examined their correlations within a large, population-based study. Between November 2000 and November 2001, we recruited all mothers and their newborns after delivery at the University of Ulm (Ulm, Germany). The current analysis included 766 mothers with available breast milk samples collected 6 weeks postpartum. Adipokine concentrations were measured with commercially available ELISAs (R&D Systems). Results: Median adiponectin concentrations in maternal serum (n = 713), cord blood (n = 709), and breast milk (n = 766) were 8.6 mg/L, 30.6 mg/L, and 10.9 μg/L, respectively. Median leptin concentrations were 12.8 μg/L in maternal serum, 7.8 μg/L in cord blood, and 174.5 ng/L in breast milk. Whereas increases in leptin concentrations with increasing birth weight, birth weight according to gestational age, and ponderal index were statistically significant in cord blood (all P values <0.0001), cord blood adiponectin was clearly related only to birth weight (P = 0.0004). Concentrations of both adipokines were moderately correlated in breast milk and maternal serum (both Spearman ρ values were 0.43; P <0.0001). Conclusions: Concentrations of adiponectin and leptin vary strongly in maternal serum, cord blood, and breast milk, with only moderate correlations between both adipokines in maternal serum and breast milk. The health implications of these patterns warrant further investigation.


Sign in / Sign up

Export Citation Format

Share Document